Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02062164
Other study ID # U1111-1131-4384c
Secondary ID DRKS0000417201GI
Status Active, not recruiting
Phase
First received
Last updated
Start date November 2013
Est. completion date January 2028

Study information

Verified date May 2024
Source University of Ulm
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The use of bariatric surgery in adolescents is controversial. On one side, bariatric surgery is the only effective treatment to achieve sustained weight loss in adults with extreme obesity. Comorbidities are reversed and mortality is reduced. In adolescents, bariatric surgery is equally effective; however, due to the paucity of long-term data, the long-term effects and risks are unknown. Thus, due to surgical risk and ethical implications, bariatric surgery is considered experimental in Germany. Nevertheless, case volumes are increasing. The aim of this study is to evaluate the benefits and risks of adolescent bariatric surgery in the context of a structured preparation and follow-up program. The study is a subproject of the study "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care" (DRKS00004172). At 5 German university centers (Ulm, Datteln, Berlin, Essen, Leipzig), youth who undergo bariatric surgery and are participants in the overall project will be enrolled in a structured preparation and follow-up program. The program is designed to improve adherence and compliance and will result in comprehensive follow-up data. In addition to the data gathered in the overall project, subjects participating in subproject 3 will undergo assessments pertinent to bariatric surgery, as proposed in the American Teen-LABS study (http://www.cincinnatichildrens.org/ research/divisions/t/teen-labs/default/). Comparison will be made with BMI matched adolescents who participate in the overall project but do not undergo bariatric surgery. In November 2014 recruitment for the overall project was completed. However, patients interested in bariatric surgery will still be recruited until September 2016. There assessment will be the same as for patients recruited earlier. However, in an amendment in December 2014, the frequency of assessment via questionnaire was reduced from biannually to annually. In addition, a travel reimbursement of 30€ for each study visit was implemented.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 66
Est. completion date January 2028
Est. primary completion date April 2018
Accepts healthy volunteers No
Gender All
Age group 14 Years to 24 Years
Eligibility Inclusion Criteria: - BMI = 35 kg/m2 with severe comorbidity or BMI = 40 kg/m2 with relevant comorbidity - completed longitudinal growth - stable social surroundings - exhaustion of conservative treatment - participation in the project "Adolescents with extreme Obesity" - adequate compliance and adherence Exclusion Criteria: - treatable causative condition - unstable medical, psychosocial or psychiatric comorbidity - alcohol or drug abuse - pregnancy - contraindication for bariatric surgery

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
bariatric surgery
The intervention takes place in the clinical care setting. The decision for surgery is made by a multidisciplinary team, according to the international guidelines and the recommendations of the German working group on obesity (AGA, www.a.g.a.de). The choice of procedure is made on an individual basis taking into consideration patient inherent factors as well as the recommendations of the operating center. Operations are conducted at certified bariatric centers according to the policies of the German working group on bariatric surgery (CAADIP), and in the context of a structured preparation and follow-up program. The program is offered by a multidisciplinary team (pediatrician, endocrinologist, surgeon, dietician, psychologist/psychiatrist, social worker) and comprises preparation for and education about the surgery and expected lifestyle changes, as well as a structured, multidisciplinary follow-up plan. Subjects sign a contract agreeing to adhere to the recommended follow-up schedule.
Other:
conservative care
Subjects will be seen by a trained study physician every 6 months. Stuctured health assessments will be conducted, and individual treatment recommendations will be made based on the patients motivation and ability(e.g. inpatient obesity rehab, exercise, dietary or behavioral intervention etc.)

Locations

Country Name City State
Germany Ambulatory Obesity Program, Charité University, Berlin Berlin
Germany Vestische Kinderklinik, University of Witten/Herdecke Datteln
Germany University Duisburg-Essen Essen
Germany University Hospital Leipzig Leipzig
Germany Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic Ulm

Sponsors (5)

Lead Sponsor Collaborator
Prof. Dr. Martin Wabitsch Charite University, Berlin, Germany, Universität Duisburg-Essen, University of Leipzig, University of Witten/Herdecke

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary BMI change from baseline 1 year postoperative
Secondary BMI every 6 months for 9 years
Secondary changes in somatic comorbidity Will be assessed via standardized physical examination, laboratory and apparative tests, and standardized patient questionnaires. every 12 months for 9 years
Secondary changes in psychosocial comorbidity Will be assessed via standardized patient questionnaires. every 12 months for 9 years
Secondary changes in psychiatric comorbidity Will be assessed via standardized psychiatric evaluation and standardized and validated patient questionnaires. every 12 months for 9 years
Secondary peri- und postoperative complications Will be assessed via physician questionnaires. every 12 months for 9 years
Secondary vitamin deficiencies Will be assessed via patient questionnaire and laboratory studies. every 6 months for 9 years
Secondary adherence with postoperative recommendations on supplements, doctors visits and nutrition Will be assessed via patient questionnaire. every 12 months for 9 years
Secondary hunger, food tolerance, gastrointestinal symptoms, dumping Will be assessed via patient questionnaire. every 12 months for 9 years
Secondary eating behavior Will be assessed via validated questionnaire (EDE-Q). every 12 months for 9 years
Secondary exercise Will be assessed via validated questionnaire (IPAQ). every 12 months for 9 years
Secondary changes in quality of life: SF36 Will be assessed via validated questionnaires (SF36). every 12 months for 9 years
Secondary changes in quality of life: IWQOL Will be assessed via validated questionnaires (IWQOL). every 12 months for 9 years
Secondary schooling, vocation, psychosocial situation, functional impairments Will be assessed via standardized patient questionnaire. every 12 months for 9 years
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2

External Links